Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 243, Issue 12, 2005, Pages 1247-1252

  Koga, Tomoyo ^a   Mawatari, Yuki ^a   Inumaru, Junko ^a   Fukushima, Mikiko ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CATARACT; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTON; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA EDEMA; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; THICKNESS; TOPICAL ANESTHESIA; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; ORBIT; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 30344464692     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0045-0     Document Type: Article

References (31)

1. Bakri SJ, Kaiser PK (2005) Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol 139:290-294 10.1016/j.ajo.2004.09.038
2. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW (2003) Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 121:271-273 12583797
3. Degenring RF, Kreissig I, Jonas JB (2004) Intraocular triamcinolone for diffuse diabetic macular edema. Ophthalmologe 101: 251-254 15007605
4. Early Treatment Diabetic Retinopathy Study Reseach Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796-1806
5. Engelman CJ, Palmer JD, Egbert P (2004) Orbital abscess following subtenon triamcinolone injection. Arch Ophthalmol 122:654-655 15078688
6. Gallardo MJ, Johnson DA (2004) Cutaneous hypopigmentation following a posterior sub-tenon triamcinolone injection. Am J Ophthalmol 137:779-780 10.1016/j.ajo.2003.09.044
7. Harbour JW, Smiddy WE, Flynn Jr HW, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405-413 8604734
8. Jonas JB, Kreissig I, Degenring R (2003) Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87 24-27 10.1136/bjo.87.1.24
9. Jonas JB, Kreissig I, Degenring RF (2003) Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 121:1663-1664 10.1001/archopht.121.11.1663-b
10. Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61 10.1001/archopht.121.5.729
11. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425-427 10.1016/S0002-9394(01)01010-8
12. Kompella UB, Bandi N, Ayalasomayajula SP (2003) Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Investig Ophthalmol Vis Sci 44:1192-1201 10.1167/iovs.02-0791
13. Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP (1999) Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: Indications, efficacy and side effects. Graefe Arch Clin Exp Ophthalmol 237:289-295 10.1007/s004170050235
14. Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology 98:1594-1602 1961650
15. Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753-759 1594222
16. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920-927 10.1016/S0161-6420(02)00975-2
17. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial. Ophthalmology 111:218-224; discussion 224-215 10.1016/ j.ophtha.2003.05.037
18. Morgan CM, Schatz H, Vine AK, Cantrill HL, Davidorf FH, Gitter KA, Rudich R (1988) Ocular complications associated with retrobulbar injections. Ophthalmology 95:660-665 3174025
19. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791-796 10.1016/S0002-9394(03)00483-5
20. Moshfeghi DM, Lowder CY, Roth DB, Kaiser PK (2002) Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection. Am J Ophthalmol 134:132-134 10.1016/S0002-9394(02)01426-5
21. Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998-1003 10.1016/ S0161-6420(98)96025-0
22. Ohguro N, Okada AA, Tano Y (2004) Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefe Arch Clin Exp Ophthalmol 242:444-445 10.1007/s00417-003-0853-z
23. Okada AA, Wakabayashi T, Morimura Y, Kawahara S, Kojima E, Asano Y, Hida T (2003) Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 87:968-971 10.1136/bjo.87.8.968
24. Otani T, Kishi S (2002) A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 134:214-219 10.1016/S0002-9394(02)01548-9
25. Penfold PL, Wen L, Madigan MC, Gillies MC, King NJ, Provis JM (2000) Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 121:458-465 10.1046/j.1365-2249.2000.01316.x
26. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA (2003) Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121:1279-1282 10.1001/archopht.121.9.1279
27. Schatz H, Madeira D, McDonald HR, Johnson RN (1991) Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109:1549-1551 1755735
28. Sutter FK, Simpson JM, Gillies MC (2004) Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111:2044-2049 10.1016/ j.ophtha.2004.05.025
29. Verma LK, Vivek MB, Kumar A, Tewari HK, Venkatesh P (2004) A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. J Ocul Pharmacol Ther 20:277-284 10.1089/1080768041725308
30. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan Jr E (1992) Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110:1155-1159 1497531
31. Yamamoto T, Hitani K, Tsukahara I, Yamamoto S, Kawasaki R, Yamashita H, Takeuchi S (2003) Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 135:14-19 10.1016/S0002-9394(02)01819-6